Anti-Human EGFR Recombinant Antibody (Panitumumab)
Recombinant monoclonal antibody to Human EGFR. Panitumumab (INN), formerly ABX-EGF, is a fully human monoclonal antibody specific to the epidermal growth factor receptor (also known as EGF receptor, EGFR, ErbB-1, and HER1 in humans).
Anti-Human EGFR Recombinant Antibody (Panitumumab)
The supplier does not provide quotations for this product through SelectScience. You can search for similar products in our Product Directory.
Recombinant monoclonal antibody to Human EGFR. Panitumumab (INN), formerly ABX-EGF, is a fully human monoclonal antibody specific to the epidermal growth factor receptor (also known as EGF receptor, EGFR, ErbB-1 and HER1 in humans). It is designed to support reliable, reproducible results in modern laboratories. It helps streamline your workflow, reduce troubleshooting, and deliver consistent performance across batches. Prominent attributes include productname and abbr.
Manufactured under rigorous quality controls, each lot is checked for key specifications to ensure lot‑to‑lot consistency. The format is optimized for ease of use and integration into existing protocols, with documentation available upon request.
Key Features / Benefits
- productname: Anti-Human EGFR Recombinant Antibody (Panitumumab)
- abbr: Panitumumab
- Target: EGFR
- Host Animal: Human
- Specificity: Tested positive against native human antigen
- Immunogen: EGFR expressed on the surface of cells (A431 cells)
Relevant Applications
- ELISA
- IP
- FC
- FuncS
- Neut
- IF
- ICC
- The EGFR antibody has been reported in applications of ELISA
